Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer/Pharmacia Clears FTC: Viagra Patent Strategy, HRT Safety Are Factors

Apr 21 2003

• By The Pink Sheet

Related Content

Pfizer’s Women’s Health Initiative: Divest FemHRT And Contraceptive Line

Jan 27 2003

Pfizer $11 Bil. Premium For Pharmacia Calibrated To Merger Savings

Jul 22 2002

Prempro Cancer Risk Addressed In 550,000 Physician Letters, Label Review

Jul 15 2002

Pfizer’s Eye-Openers: Company Licenses Insomnia, Blindness Agents

Dec 23 2002

Pfizer Darifenacin, Yamanouchi NDAs Filed For Urinary Incontinence

Feb 24 2003

Pfizer Darifenacin Will Be Divested As Condition For EU Approval Of Merger

Mar 03 2003

Oxytrol Medicaid Reimbursement Expected In 75% Of States At Launch

Mar 31 2003

Pharmacia R&amp;D Head Ando Leaves For Celltech; Will Still Work With Pfizer

Apr 21 2003

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window